Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Varvares

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Oral Oncology|May 14, 2023
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patientsAndrew J Holcomb, Nathan Farrokhian, Claire Tolan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Oral Oncology|May 14, 2023
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patientsAndrew J Holcomb, Nathan Farrokhian, Claire Tolan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Pageof 4